INTRODUCTION
Lyme disease is a multi-system illness caused by Borrelia burgdorferi (Bb) . Diagnosis of the disease is based on clinical manifestations and serological tests (1) . Soon after infection, a specific immunoglobulin (IgM) is produced. This response peaks between 3 to 6 weeks and is followed by the production of IgG specific antibody to Bb (1) . It has been reported that some patients who exhibit signs and symptoms highly suggestive of Lyme disease do not produce antibodies to Bb infection (2, 3, 4, 5, 6) .
The immune response is dependent on the ability of the immune system to discriminate "self" from "nonself" enabling the host to recognize and kill harmful microorganisms.
Specialized leukocytes including macrophages, monocytes, Langerhan's and Kupffer's cells process and present antigen to T-cells thereby mediating an immune response (7) . The HLA class II antigen is a transmembrane, polymorphic glycoprotein that assists in presenting antigenic peptides to CD4
+ helper T cells. The activated CD4 + helper T cells stimulate B-cells to produce specific antibody. Polymorphism displayed by the HLA molecules influences the immune response and may predispose the individual to disease (8) . Certain HLA antigens are associated with a higher risk of contracting a particular disease (9, 10, 11, 12) . For instance, of Caucasian ankylosing spondylitis patients, 88% have HLA-B27 while only 8% of American Caucasian controls have HLA-B27 (8) . Seronegative spondyloarthropathies in association with HLA-B27 have also been documented (13) . In addition, an increased frequency of HLA-DR4 in antibiotic treatment resistant chronic Lyme arthritis has been reported (14) .
We investigated whether the presence or absence of certain HLA class II-linked genes correlated with antibody production in LD. To examine our hypothesis, we determined the immunogenetic profiles of seropositive LD patients, seronegative LD patients and normal controls.
MATERIALS AND METHODS
Patients were recruited from the Lyme Disease Center at Long Island Jewish Medical Center. Healthy donors were recruited from the hospital and physician's office staff. There were three groups of patients studied: [1] Seropositive LD patients with a history of exposure, 
Cell Isolation
Macrophages and lymphocytes were isolated and tested for Bb. In brief, 25 ml of whole blood from LD patients and healthy donors were collected in heparinized tubes. Peripheral blood mononuclear cells (PBMC) were isolated by centrifuging whole blood over Lymphoprep (GIBCO Life Technologies, Gaithersburg, MD); the mononuclear cell layers were cultured in 25 cm 2 flasks for 48 to 72 hours (2) (RPMI 1640 medium with 10% fetal bovine serum, 5% CO 2 incubation at 37 o C). Non-adherent cells (lymphocytes) were separated and washed. Nested PCR was performed on both adherent and non-adherent cells.
PCR
Ten µ1 of TE buffer was added to each of the pellets from 1/5 the macrophage fraction and 1/10 the lymphocyte fraction, then boiled for 30 minutes. CSF was centrifuged at 16,000 x g for 30 min, 10 µl TE buffer was added to the pellets then boiled for 30 min. MgCl 2 was added to saturate EDTA in the TE buffer. The nested PCR was modified from a previously published procedure (2, 15) . For OspA PCR, the first reaction mixture of 50 µl contained 10 µl cell lysate, l x PCR buffer, 1.5 mM MgCl2, 200 µM dNTP, 0.25 µM of each external primer bp; and internal primers, 5'-GCAAAATGTTAGCAGCCTTGACG-3' (forward) and5'-CTGTGTATTCAAGTCTGGTTCC-3' (reverse), 392 bp. PCR products were analyzed on a 1.5% agarose gel. Ten fg of Bb B31 DNA served as positive control and water was used as a negative control. The PCR hoods were UV sterilized for at least 30 minutes prior to use. Each step in the nested PCR was done in a different room using a different hood. Both negative and positive controls were used in each assay. The positive control was never added in the same room in which the PCR was performed.
HLA Typing
DNA was extracted from PBMCs using the Invitrogen Easy-DNA kit (Invitrogen, San Diego, CA).
All specimens were genotyped for HLA-DRB by polymerase chain reaction-sequence specific oligonucleotide (PCR-SSO) (Dynal A. S, Oslo, Norway). The Dynal RELI SSOHLA-DRB strip was banded with 36 probes (35 specific and 1 control). This test distinguishes 125 different HLA-DRB1 allele groups, 10 DRB3 groups, 2 DRB4 groups and 7 DRB5 groups. Based on the kit, some oligonucleotide defined groups were sets of multiple alleles. The assay procedure followed the manufacturer's instructions. The HLA-DRB typing is assigned by reading the blue lines on the HLA-DR typing strip to determine which HLA-DR alleles are present in the DNA samples. This homozygous hybridization pattern was read by using the Dynal RELI SSO Pattern Matching Program.
Statistical Analysis
Comparisons of HLA-DR types in seropositive patients, seronegative patients or healthy donors were made using contingency tables (two-by-two) from which the odds ratio and P value were calculated by Fisher's exact test (two-sided). P values less than 0.05 were considered statistically significant.
RESULTS
Forty patients with various manifestations of LD were included in this study. Of the twenty-two seropositive patients, 9 were female and 13 male patients ranging in age from 35 to 83 (mean, 56). Signs and symptoms in this subgroup included the following: 6 (27%) had tick bites, 8 (36%) had acute erythema migrans (EM), 6 (27%) had primarily neurological symptoms, 5 (23%) had primarily arthritic complaints and 5 (23%) had a mixed neurological and arthritic picture ( Table 1 ). There were eighteen seronegative patients (14 females and 4 males) ranging in age from 24 to 71 (mean, 47). Of these, 6 had tick bites (33%), 3 (17%) had EM rashes, 9 (50%) had primarily neurological complaints, 6 (33%) predominantly arthritic problems and 4 (22%) a mixed neurological and arthritic picture. Twenty-six healthy volunteers (14 females and 12 males) ranging in age from 21 to 59 (mean, 37) without symptoms or exposure to a Lyme endemic area were enrolled in the study.
Twenty-two patients had positive Western blots and ELISAs. Eighteen were seronegative. Of twenty-two seropositive LD patients, two were positive on OspA PCR of mononuclear cells and 3 were positive for CSF using the same method. Of eighteen seronegative LD patients, 14 were OspA PCR positive on mononuclear cells and 5 were positive on CSF. None of twenty-six healthy donors tested positive on any of the tests (Table 3 ).
The frequency of HLA-DRB1*0701, *0703, *0704 which determine serological antigen HLA-DR7 was significantly higher in seropositive LD patients than in seronegative LD patients (40.9% vs. 5.6%, OR=11.8, P=0.0126). There was a similar finding on the alleles shown on Table 4 , which encode serologically determined antigen DR6. These alleles frequently represented HLA type in seropositive LD patients (40.9% of seropositive vs. 5.6% of seronegative, OR=11.8, P=0.0126). Taken all together, 16 of 22 seropositive patients had alleles which determine either DR7 antigen or the alleles which determine DR6 antigen, or the alleles which determine both antigens compared with only 2 out of 18 seronegative patients (72.7% vs. 11.1%, OR=21.3, P=0.0001) ( Table 4) .
HLA-DRB1*01021 and HLA-DRB1*0101, *0104, *0105 which carry serologically determined antigen HLA-DR1 was present more frequently in seronegative than in seropositive LD patients (38.9% vs. 4.5%, OR=13.4, P=0.0138).
The frequency of HLA-DR7 alleles in healthy donors was similar to seropositive LD patients, but was significantly different from seronegative LD patients (34.6% vs. 5.6%, OR=9.0, P=0.0311). However, the frequency of DR1 alleles and the frequency DR6 alleles were not significantly different between healthy donors and LD patients. The frequency of DR4 alleles was found in 44.4% of seronegative and 22.7% of seropositive patients (OR=2.7, P=0.185). There was no significant difference in the frequency of DRB3, DRB4 and DRB5 between the three groups (data not shown).
DISCUSSION
The presence of certain HLA alleles with seronegativity to disease has been reported in malaria (10), HIV (16, 17) , rheumatoid arthritis (RA) (18) and spondylarthropathies (SpA) (19) . HLA-DR1 was associated with seronegative/weakly seropositive RA and HLA-DR4 was associated with seropositive RA. An HLA-B27 correlation with seronegative SpA is another example of disease associated with a hereditary marker (19) . In addition to disease related antibody production, HLA-B70 and HLA-B35 correlate with non-responsiveness to the hepatitis B surface antigen (HBs) vaccine and, HLA-B46 and HLA-B7 are related to HBs antibody production (20) . HLA-DR4 and HLA-DR7 are also involved in the presentation of apple and pollen antigens (21).
Our results provide evidence of a correlation between certain HLA genotypes and the ability to mount an antibody response to Bb. In this study, 9 of 22 (40.9%) seropositive LD patients and only 1 out of 18 (5.6%) seronegative LD patients had HLA-DR7 alleles. There was a similar finding for the HLA-DR6 alleles. The percentages of DR7 alleles and DR6 alleles present in normal controls were somewhere between that of seronegative and seropositive patients (34.6% and 23.1% respectively). Taken together, 16 of 22 seropositive had DR7 alleles or DR6 alleles while 2 patients had both. This suggests that DR7 and DR6 may be independently involved in antibody production to Bb infection. It was also found that the presence of DRB1*01021 and DRB1*0101,0104,0105 was associated with non-responsiveness to Bb antigen and poor to absent antibody production. Seven of 18 (38.9%) seronegative LD patients had these alleles while only 1 out of 22 (4.5%) seropositive LD patients carried these alleles.
The total number of tests performed included the 15 comparisons shown in Table 4 as well as 9 comparisons on DRB3, DRB4 and DRB5 (not shown), for a total of 24 tests. If the null hypothesis that the three groups did not differ were true, then we would expect an average of about one significant result at the 5% level in groups of 24 tests (24 × 0.05 = 1.2). The binomial expansion also shows that if the null hypothesis were true, no more than 2 statistically significant results would occur in 88% of groups of 24 tests. Since our data yield 6 significant results (Table 4) , it seems reasonable to conclude that at least some of them identified true differences between the three groups.
Interestingly, there are 2 seropositive LD patients who were OspA PCR positive on their mononuclear cells. Patient #7 and patient #13 were seropositive for 3 and 6 months respectively and then became seronegative. Patient #13 was OspA PCR positive for 7 months, on all 4 OspA PCR tested during that period. On HLA testing, patient #7 had DR7 alleles, and #13 did not. The remainder of the seropositive LD patients remained seropositive for years (22, 23, 24) . Others have described a correlation between HLA-DR4 (DRB1*0401, DRB1*0403 and DRB1*0404) and non-responsiveness to antibiotic therapy in Lyme arthritis (14) .
The genes encoding HLA class II are highly polymorphic. Several alleles may be present at one locus. Each functional allele determines at least one HLA antigen defined by serologic or cellular assay. Several closely related alleles, which encode different molecules, can determine the same serologic antigen (8) . The HLA molecular typing of LD patients was carried out by a Dynal RELI SSO test kit. According to the kit, some oligonucleotide-defined groups are sets of multiply related alleles. In LD patients, DR7 is encoded by one set of alleles; DR1, 2 sets; DR4, 4 sets, and DR6, 7 sets (Table 4 ).
The HLA class II molecule is a transmembrane heterodimeric glycoprotein. The α1 and β1 domains of the class II molecule forms a peptide-binding groove open at both ends allowing a 10-25 amino acid peptide to bind restricting the recognition of peptide by CD4 + T cells (25, 26, 27) . HLA class II restricted antigens are primarily exogenous antigens that are first internalized either by endocytosis or phagocytosis, then processed in endosomes or lysosomes (28) . An in vitro study has shown that Bb is degraded in lysosomes of mouse macrophages soon after being ingested (29) . Filgueira et al (30) demonstrated that human dendritic cells were able to engulf and process live Bb. By using double staining, they found that Bb antigen and HLA class II molecules co-localized in the lysosomal compartment. The outcome of the interaction between class II molecules and peptides was peptide sequence dependent (31, 32) . Different types of class II selectively bind different sets of peptides (27, 33) . Lack of certain types of class II antigens may result in antibody deficiency in LD patients. Our study provides evidence that HLA alleles are involved in antibody responsiveness or non-responsiveness to Bb infection. A low frequency of HLA-DR7 alleles and HLA-DR6 alleles and a high frequency of HLA-DR1 alleles may contribute to nonresponsiveness of antibody production in LD patients. Thus, genetic predisposition may be a critical factor in the regulation of the host immune response and the diagnosis and prognosis of Lyme disease.
